<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="751388" id="root" date="1997-07-23" xml:lang="en">
<title>CHINA: Shangdong Xinhua to issue 10 mln A-shares.</title>
<headline>Shangdong Xinhua to issue 10 mln A-shares.</headline>
<dateline>HONG KONG 1997-07-23</dateline>
<text>
<p>Shangdong Xinhua Pharmaceutical Co Ltd said on Wednesday it planned to raise 32.75 million yuan after expenses by issuing 10 million A-shares to fund its production of caffeine, nisoldpine and melatonin.</p>
<p>The medicine maker said the China Securities Regulatory Commission had granted final apporval for listing the A-shares and the listing prospectus would be published on Thursday.</p>
<p>The company said the A-shares would be issued at 3.45 yuan per share to public investors in China.  </p>
<p>The 10 million new A-shares and another 2.5 million existing A-shares held by company employees will make up a total of 12.5 million A-shares or 2.9 percent of the company's enlarged share capital. The A-shares will be listed in Shenzhen.</p>
<p>A-shares are shares of Chinese enterprises listed in Shanghai and Shenzhen for domestic investors only.</p>
<p>Hubei Securities Co Ltd is the lead underwriter of the issue and sponsors are China Southern Securities Co Ltd, Shangdong International Trust &amp; Investment Co Ltd and Hubei Securities.</p>
<p>The total number of H-shares will be unchanged at 150 million shares following the A-share issue, but their percentage of the company will be diluted to 35.1 percent from 35.9 percent.</p>
<p>H-shares are Chinese enterprises' shares listed in Hong Kong. Trading in the company H-shares is due to resume on Wednesday following a one-day suspension.</p>
<p>The company reported total sales revenue of 842.2 million yuan in 1996, up from 711.9 million yuan in 1995 and 533.7 million in 1994.</p>
<p>-- Hong Kong Newsroom (852) 2843 6370</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="CHINA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-23"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-23"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C17">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-23"/>
  </code>
  <code code="C171">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-23"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-23"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-07-23"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-07-23"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="HONG KONG"/>
<dc element="dc.creator.location.country.name" value="CHINA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
